Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Side-effects news

Show

From To
Popular HIV drug may cause memory declines

The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.

Published
28 September 2012
From
Eurekalert Medicine & Health
Stamp-Sized Device Could Cut Liver Test Costs

A paper-based device about the size of a postage stamp could improve testing for drug-induced liver toxicity in the developing world, researchers reported.

Published
21 September 2012
From
MedPage Today HIV/AIDS
Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

An integrated analysis of data from phase II and III trials showed that the 'Quad' single-tablet regimen has antiviral efficacy at least as good as comparison regimens

Published
12 September 2012
By
Liz Highleyman
High rate of infections in people with HIV receiving Bio-Alcamid treatment for facial lipoatrophy

Bio-Alcamid treatment for HIV-related lipoatrophy is associated with a high-rate of infectious complications, Canadian investigators report in the online edition of Clinical Infectious Diseases. The infections typically developed

Published
10 September 2012
By
Michael Carter
Salix Says FDA Decision Delayed on HIV-Associated Diarrhea Drug

Salix Pharmaceuticals Ltd. (SLXP), a maker of antibiotics and gastrointestinal drugs, said a decision by U.S. regulators on its new medicine to treat diarrhea in people with HIV has been postponed.

Published
06 September 2012
From
Bloomberg
HIV and antiretroviral therapy increase risk of cardiovascular disease, shows meta-analysis

People with HIV have an increased risk of cardiovascular disease, and the risk is higher still for those taking antiretroviral therapy, results of a meta-analysis published in

Published
06 September 2012
By
Michael Carter
India: Safer anti-HIV drugs to replace Stavudine

Concerned over the ill effects of Stavudine d4T, a first-line drug against HIV for long, the Centre plans to replace it with safer and better-tolerated Tenofovir and Zidovudine.

Published
04 September 2012
From
Indian Express
Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

Treatment with ritonavir-boosted atazanavir is associated with a much higher risk of kidney stones compared to other ritonavir-boosted protease inhibitors, Japanese investigators report in the online edition of

Published
29 August 2012
By
Michael Carter
Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

Italian investigators have found evidence of worsening glucose tolerance in highly treatment-experienced HIV-positive patients treated with nucleoside-sparing regimens. The small study, which is published in the online edition

Published
24 August 2012
By
Michael Carter
Starting HIV treatment reduces risk of kidney disease

Starting HIV treatment reduces the risk of chronic kidney disease, US investigators report in the online edition of AIDS. This was especially the case for patients who

Published
23 August 2012
By
Michael Carter

Filter by country